Gastro Medical News about Hepatoblastoma

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Long-term Treatment Results of Hepatoblastoma at a Single Institution in Taiwan
Journal of Pediatric Hematology/Oncology, 11/06/09

Hou JY et al. – The commonest toxicity was febrile neutropenia. There was no cardiotoxicity event. In conclusion, with sequential combination of surgery and chemotherapy, the treatment results for hepatoblastoma were satisfactory as compared with other groups.

<< Previous
Safety and Efficacy of Steroid-Free Immunosuppression with...

Next >>
Globus sensation and increased upper esophageal sphincter...

Mixed hepatoblastoma and teratoma of the liver in a 3-year-old child: a unique combination and clinical challenge
Diagnostic Pathology, 11/17/09 Relevance Score: 87%

Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma
New England Journal of Medicine, 10/22/09 Relevance Score: 87%

Hepatoblastoma, cisplatin, and ototoxicity
Cancer, 10/12/09 Relevance Score: 83%